Behrad Derakhshan, Chief Business Officer at Edgewise Therapeutics, Inc. (EWTX), sold 1,718 shares at $18.91 ($32K) on 2024-05-02, disclosed to the SEC on 2024-05-03.
Open-market sale of $32k EWTX by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| EWTX | SELL | 2025-05-07 | $28K | — | Filing → |
| EWTX | SELL | 2025-02-07 | $300K | — | Filing → |
| EWTX | SELL | 2024-09-24 | $2.4M | — | Filing → |